Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm

Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm

Abstract The present study entails the systematic development and validation of a stability-indicating RP-HPLC method for the analysis of sitagliptin and ertugliflozin in a fixed-dose combination. Analytical quality by design (AQbD) concepts were used to define critical method variables, employing P...

Full description

Bibliographic Details
Main Authors:	Sunitha Gurrala, Shivaraj, Panikumar Durga Anumolu, Haripriya D, Subrahmanyam CVS
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2023-06-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	AQbD HPLC Sitagliptin Ertugliflozin Stability-indicating
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502023000100379&tlng=en

Similar Items

Multivariate optimization and evaluation of quaternary mixture in bulk and co-formulated dosage forms by central composite design
by: Rama Tulasi Jampana, et al.
Published: (2021-05-01)

Novel stability-indicating RP-UPLC method for simultaneous estimation of sitagliptin and ertugliflozin in bulk and pharmaceutical formulations
by: Ramya kuber B, et al.
Published: (2021-04-01)

Integrated Application of Risk Management Techniques in Developing an Analysis Method for Traditional Chinese Medicine: A Case Study of a Percolation Solution for Xiaochaihu Capsules
by: Mintong Zhao, et al.
Published: (2024-08-01)

Quality by Design (QbD) Based Method for Estimation of Xanthohumol in Bulk and Solid Lipid Nanoparticles and Validation
by: Vancha Harish, et al.
Published: (2023-01-01)

Development and validation of a UPLC-MS/MS method for the simultaneous estimation of Ertugliflozin and Sitagliptin in bulk and tablet dosage forms: Assessment of greenness and blueness
by: Voohitha Manukonda, et al.
Published: (2025-03-01)

Implementation of quality by design and green chemistry principles to validate the stability indicating method on UHPLC for the simultaneous quantification of Glycopyrronium, Fluticasone, Vilanterol in inhaled formulation
by: Anitha L, et al.
Published: (2024-12-01)

Development of a QAMS Analysis Method for Industrial Lanolin Alcohol Based on the Concept of Analytical Quality by Design
by: Kaidierya Abudureheman, et al.
Published: (2024-09-01)

Development and validation of stability-indicating RP-HPLC method for the simultaneous determination of ertugliflozin pidolate and metformin hydrochloride in bulk and tablets
by: K. Sravana Kumari, et al.
Published: (2020-10-01)

Central composite design (CCD) approach to develop HPLC method for caffeine: Application to coffee samples analysis of Jazan region, Saudi Arabia
by: Asim Najmi, et al.
Published: (2024-01-01)

AQbD TLC-densitometric method approach along with green fingerprint and whiteness assessment for quantifying two combined antihypertensive agents and their impurities
by: Hend M. Nagieb, et al.
Published: (2024-01-01)

Quality assessment, HPTLC-DPPH, analytical quality by design based HPTLC method development for estimation of piperine in piper species and marketed formulations
by: Amruta Balekundri, et al.
Published: (2024-03-01)

Perspectives in modeling and model validation during analytical quality by design chromatographic method evaluation: a case study
by: Yongzhi Dong, et al.
Published: (2021-09-01)

AQbD-guided stability indicating HPLC method for azelnidipine and chlorthalidone fixed-dose combination tablet: a green approach
by: Rajvi Agrawal, et al.
Published: (2024-12-01)

Developing an Improved UHPLC Method for Efficient Determination of European Pharmacopeia Process-Related Impurities in Ropinirole Hydrochloride Using Analytical Quality by Design Principles
by: Tim Tome, et al.
Published: (2020-06-01)

Development and Validation of a Stability-Indicating UPLC Method for the Determination of Hexoprenaline in Injectable Dosage Form Using AQbD Principles
by: Jesús Alberto Afonso Urich, et al.
Published: (2021-10-01)

Expediting Disulfiram Assays through a Systematic Analytical Quality by Design Approach
by: João Basso, et al.
Published: (2021-07-01)

Multivariate optimization of liquid chromatographic conditions for determination of dapagliflozin and saxagliptin, application to an in vitro dissolution and stability studies
by: Sunitha Gurrala, et al.
Published: (2021-04-01)

Box–Behnken design-assisted optimization of RP-HPLC method for the estimation of evogliptin tartrate by analytical quality by design
by: Khushbu Patel, et al.
Published: (2023-07-01)

Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
by: Derosa G, et al.
Published: (2018-09-01)

Rheology of Complex Topical Formulations: An Analytical Quality by Design Approach to Method Optimization and Validation
by: Lucas Chiarentin, et al.
Published: (2023-06-01)

Development and validation of RP HPLC method for determination of metformin and sitagliptin in bulk and pharmaceutical dosage form
by: Kavitha D., et al.
Published: (2017-04-01)

Application of the Analytical Procedure Lifecycle Concept to a Quantitative <sup>1</sup>H NMR Method for Total Dammarane-Type Saponins
by: Wenzhu Li, et al.
Published: (2023-06-01)

Possibilities and limitations of computer assisted chiral HPLC method development for ozanimod on polysaccharide based chiral stationary phases
by: Elek Ferencz, et al.
Published: (2024-11-01)

Stability indicating method development and validation for simultaneous estimation and quantification of Ertugliflozin and Metformin in bulk and tablet dosage form
by: Bhawani Sunkara, et al.
Published: (2021-01-01)

Effectiveness of ertugliflozin during Ramadan fasting in patients with type 2 diabetes mellitus: a real-world study (ErtuRamadan study)
by: Md Faruque Pathan, et al.
Published: (2025-02-01)

Sitagliptin phosphate: isolation and identification of two degradation products formed under acid conditions and determination of in vitro cytotoxicity
by: Alini Dall Cortivo Lange, et al.
Published: (2023-07-01)

Ertugliflozin in the treatment of type 2 diabetes mellitus
by: Joel C Marrs, et al.
Published: (2020-11-01)

New SGLT2 inhibitor ertugliflozin: safe and effective in the management of type 2 diabetes
by: V. V. Salukho, et al.
Published: (2020-05-01)

Analytical Quality by Design (AQbD) Approach to the Development of Analytical Procedures for Medicinal Plants
by: Geonha Park, et al.
Published: (2022-11-01)

Development of a Unified Reversed-Phase HPLC Method for Efficient Determination of EP and USP Process-Related Impurities in Celecoxib Using Analytical Quality by Design Principles
by: Tim Tome, et al.
Published: (2020-02-01)

Environmentally sustainable analytical quality by design aided RP-HPLC method for the estimation of brilliant blue in commercial food samples employing a green-ultrasound-assisted extraction technique
by: Chakraborty Atyurmila, et al.
Published: (2023-12-01)

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia
by: Masahiro Fukuda, et al.
Published: (2019-03-01)

Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats
by: Henry A. Palfrey, et al.
Published: (2024-07-01)

Oxidative stress markers in liver in streptozocin-induced diabetic rats: effects of metformin and sitagliptin
by: Şamil Öztürk, et al.
Published: (2020-12-01)

Correlation of results between validated in-house analysis method with new pharmacopeia monograph for analysis of Sitagliptin Phosphate API
by: SOLMAZ GHAFFARI, et al.
Published: (2018-03-01)

An Effective Delivery System of Sitagliptin Using Optimized Mucoadhesive Nanoparticles
by: Afzal Haq Asif, et al.
Published: (2018-05-01)

The Impact of Sitagliptin on Sodium Valproate-Induced Autism in a Mouse Model
by: Ahmed Sudan Abbas, et al.
Published: (2024-09-01)

Cardioprotective Effect of Quercetin and Sitagliptin in Doxorubicin-Induced Cardiac Toxicity in Rats
by: Aziz TA
Published: (2021-03-01)

Sitagliptin-induced hiccups: A rare side effect
by: Prabhat Agrawal, et al.
Published: (2022-01-01)

Regulation of Adropin by Sitagliptin monotherapy in participants with newly diagnosed type 2 Diabetes
by: Qiu Wang, et al.
Published: (2022-12-01)